14K prolactin derived 14‐mer antiangiogenic peptide targets bradykinin‐/nitric oxide‐cGMP‐dependent angiogenesis

14K prolactin derived 14‐mer antiangiogenic peptide targets bradykinin‐/nitric oxide‐cGMP‐dependent angiogenesis

Over the past few decades, VEGF‐targeted antiangiogenic therapy for cancers has gained increasing attention. Nevertheless, there are still several limitations such as the potential resistance mechanisms arising in cancer cells against these therapies and their potential adverse effects. These limita...

Full description

Saved in:
Bibliographic Details
Main Authors: Jaeok Lee, Pavitra Kumar, Suganya Natarajan, So Hyeon Park, Syamantak Majumder, Lakshmikirupa Sundaresan, Kambadur Muralidhar, Jong‐Soon Choi, Hwa Jeong Lee, Suvro Chatterjee
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:FEBS Open Bio
Subjects:
anti‐angiogenesis
antiangiogenic peptide
bradykinin
endothelial nitric oxide synthase
prolactin
Online Access:https://doi.org/10.1002/2211-5463.13895
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/2211-5463.13895

Similar Items